Login / Signup

Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation.

Xiang-Yu ZhaoZheng-Li XuXiao-Dong MoYu-Hong ChenMeng LvYi-Fei ChengHuan ChenYing-Jun ChangLan-Ping XuYu WangXiao-Hui ZhangKai-Yan LiuXiao-Jun Huang
Published in: Leukemia (2021)
Keyphrases
  • allogeneic hematopoietic stem cell transplantation
  • acute myeloid leukemia
  • acute lymphoblastic leukemia
  • low dose
  • bone marrow
  • free survival